This Chemical Company's Stock Up 54% In 1 Month, Income Amplified Sharply At Rs. 42086 Lakh: Check Details

The share price of Sree Rayalaseema Hi Strength Hypo Ltd. is gaining in the stock market sharply both in the long term and short term basis. This small-cap company manufactures Sodium Dichloroisocyanurate - SDIC. Check the stock's performance in NSE for investment.

Stock to Watch: NSE performance

The current market price of Sree Rayalaseema Hi Strength Hypo Ltd. stood at Rs. 654.80/share on NSE, gaining by 14.95%, till last traded. In the last 5 days, the share price of this company has surged by 14.08% on NSE, and in the last 1 month, its share price has surged by 54.20%. In the past 6 months, its stock price has surged by 94.68%. In the last 1 year its stock price gained by only 93.36%. This stock has given consistently high returns to its investors. Today, it has reached a 52-week high level.

The 52-week high level of this stock is Rs. 669.00, and the 52-week low level of this stock is Rs. 274.00.

Market capitalization	Current market price	5 days performance	6 Months performance
Rs. 1,118 crore	Rs. 654	14.08%	94.68%

Financial performance

According to data available with NSE, in Q4 FY22, the company's total income stood at Rs. 42,086.86 lakh, as against Rs. 29,553.47 lakh in the previous quarter. The company's profit before tax or PBT was reported at Rs. 4,380.69 lakh in Q4 FY22, as against Rs. 4,107.98 lakh in Q3 FY22. The company's net profit was reported at Rs. 3,732.85 lakh in Q4 FY22, as against Rs. 2,659.46 lakh in Q3 FY22.

The company is a front-ranking producer of Monochloro Acetic Acid. Manufactured by the scientific crystallizer technology, the product meets international quality standards. Monochloro Acetic Acid is used by all leading manufacturers of Non-Steroid Anti-Inflammatory Drugs, other pharmaceuticals, pesticides, organic chemicals etc., according to the company

Disclaimer

Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, and the author are not liable for any losses caused as a result of decisions based on the article.